Condition: Epilepsy, Drug Resistant · Sponsor: Xuanwu Hospital, Beijing
The primary objective of this research is to study the efficacy and safety of deep brain stimulation (DBS) of subthalamic nucleus (STN) as adjunctive therapy for reducing the frequency of seizures in drug-resistant focal motor epilepsy.
This description comes directly from the study's public registry record.
Liankun Ren, MD · +86 13681576621 · renlk2022@outlook.com
Always discuss trial participation with your own doctor first.
| Xuanwu Hospital, Beijing | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06248333